BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 502643)

  • 1. [Neuraminidase activity of inactivated influenza vaccines].
    Buchowicz I; Wrzos H; Filczak K; Bańkowski A; Korbecki M
    Med Dosw Mikrobiol; 1979; 31(2):103-10. PubMed ID: 502643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of measuring the neuraminidase activity and total protein in influenza virus preparations of an allantoic nature].
    Firsov LN; Vepritskii AA; Vostriukhina OA; Chuprunov VP
    Tr Inst Im Pastera; 1979; 52():142-8. PubMed ID: 550537
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuraminidase assay of influenza vaccines.
    Bevan AM; Furminger IG; Smith CH
    Dev Biol Stand; 1975; 28():173-80. PubMed ID: 1126567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimal temperature of enzyme activity and heat resistance of neuraminidases as attenuation markers for influenza viruses].
    Profeta ML; Ferrante P; Kotseva R
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):410-7. PubMed ID: 597391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Inactivated influenza vaccines.
    Dowdle WR
    N Engl J Med; 1973 Dec; 289(24):1309-10. PubMed ID: 4127184
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative analysis of influenza virus strains isolated in Poland during the epidemic season 1981-1982].
    Loza-Tulimowska M; Isaczenko WA; Lubowcewa OW; Iwanowa WT; Zakstelskaja LJ; Semkow RA
    Med Dosw Mikrobiol; 1984; 36(1):27-32. PubMed ID: 6738227
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorometric assay for the measurement of viral neuraminidase in influenza vaccines.
    Lambré CR; Chauvaux S; Pilatte Y
    Vaccine; 1989 Apr; 7(2):104-5. PubMed ID: 2750267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the quantitative hemagglutinin content in influenza vaccine by means of radial immunodiffusion].
    Chubarova NI
    Tr Inst Im Pastera; 1979; 52():128-32. PubMed ID: 121647
    [No Abstract]   [Full Text] [Related]  

  • 10. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolysis and fusion by influenza viruses with heat-inactivated neuraminidase activity.
    Hosaka Y; Seriburi O; Moran MG; Yasuda Y; Fukai K; Nerome K
    Biken J; 1982 Jun; 25(2):51-62. PubMed ID: 7138491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A (H1N1) 2009 monovalent vaccine: laboratory confirmation of vaccine breakdowns.
    Arya SC; Nirmala A
    Vaccine; 2009 Nov; 27(49):6808. PubMed ID: 19765396
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase- and hemagglutinin-inhibiting antibodies in serum and nasal secretions of volunteers immunized with attenuated and inactivated influenza B-Eng-13-65 virus vaccines.
    Downie JC
    J Immunol; 1970 Sep; 105(3):620-6. PubMed ID: 5311581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Factors affecting the results of determining hemagglutinin in inactivated influenza vaccines].
    Popov VF; Bizhanov GI; Lonskaia NI; Kastrikina LN
    Tr Inst Im Pastera; 1982; 59():96-8. PubMed ID: 6821267
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunogenic activity of the influenza virus dependent on ne uraminidase (author's transl)].
    Isaeva EI; Rovnova AI; Kosiakov PN
    Vopr Virusol; 1975; (5):525-8. PubMed ID: 1210315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influenza vaccination in dialysis patients].
    Haldimann B; Descoeudres C
    Schweiz Med Wochenschr; 1978 Jan; 108(2):52-5. PubMed ID: 622534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difficulties in standardizing the neuraminidase content of influenza vaccines.
    Gérentes L; Kessler N; Aymard M
    Dev Biol Stand; 1999; 98():189-96; discussion 197. PubMed ID: 10494973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro markers for measuring residual virulence for men of live attenuated influenza viruses.
    Boudreault A; Diaz-Rodriguez P; Lecomte J
    Dev Biol Stand; 1977 Jun 1-3; 39():33-40. PubMed ID: 604117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza and influenza immunization.
    Fulginiti VA
    Ariz Med; 1976 Dec; 33(12):999-1006. PubMed ID: 797353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.